Doosan Robotics signed MoU with Guangxi_Pinge Digital Industry Intelligence for the development and sale of collaborative robot medical solutions.
On this day, Bai Lan (Deputy Director of the Guangxi Commerce Department) and 20 trade delegations from the Guangxi government of China also attended and discussed support measures to assist Doosan Robotics to accelerate market expansion in China via the Guangxi Free Trade Zone policy.
Through this agreement, both companies develop and commercialize a medical solution that can analyze numerous types of samples at once by modularizing the entire process, including sample homogenization, microbial culture, microbial inoculation, detection, and identification. Sample input, result output, and real-time experiment monitoring are also provided.
It is expected that this medical solution will be used in various industries that require microbiological analysis, such as F&B and cosmetics sectors, as well as healthcare.